Meaningful Use Delays Proposed

2014 CalendarCMS proposed changes to meaningful use program.

Still have concerns about your ability to meet the requirements to attest for meaningful use? The CMS has stepped in with a proposal to give health care providers a little more time. But before you start the celebration, remember this is simply a proposed change, and if approved, will not be in effect until August at the earliest.

How this change affects you.

CMS has proposed a change that affects the software system you are required to use in 2014, which in turn affects 2014 attestations. If passed:

  • 2011 CEHRT certified products will still be valid for meaningful use attestation in 2014.
  • You may postpone updating your software system to an ONC 2014 certified product for three months, or August 2014 at the earliest.
  • If you were on track to begin Stage 2 in 2014, you may continue to demonstrate Stage 1 criteria until 2015. You may use 2011 CEHRT software in 2014 as long as it is updated to the 2013 Stage 1 objectives and measures.
  • You may begin attestation for Stage 2 in 2015, which will require an ONC 2014 certified product.

Remember, if passed the delay will not be indefinite. There will come a time when Stage 2 criteria will be required to attest using an ONC 2014 Edition certified product. View the official document.

OfficeMate/ExamWRITER V11.1 is fully certified to meet all meaningful use requirements for Stage 1 or Stage 2 attestation. Learn more about OfficeMate/ExamWRITER, or to upgrade your OfficeMate/ExamWRITER to the most current version, visit MyInstallCenter.

Still have questions? Eyefinity is tracking meaningful use news closely and will keep you informed as developments occur. If you have any questions, contact us at MeaningfulUse@eyefinity.com.

Patients And Patience: Will Quality Of Care Suffer Because Providers Miss The Point Of Meaningful Use?

Steve Baker, President of Eyefinity

Steve Baker, President of Eyefinity

Planning and thinking about the future are critical to applying EHRs in a truly meaningful way – a goal that must be achieved to build the most interactive and patient-driven healthcare system in the world. Read more in this article by Eyefinity president, Steve Baker.

MU Core Measures Challenging You?

Running into issues with Meaningful Use (MU)?Meaningful Use badge

You’re not alone! Social media is filled with comments and questions from EPs – just like yourself – who are knee-deep in Meaningful Use core measure challenges.

We’ve heard from many doctors that the most challenging core measure in MU Stage 2 is Measure 17. Let’s examine it more closely.

Simply put, Measure 17 requires that you use secure messaging to communicate with patients on relevant health information, and give them the opportunity to view and download their medical information. Specifically, 5% of your patients must send you a secure electronic communication.

The key concept behind this goal is Patient Engagement.

So why is CM17 so tough to attest? In our opinion it’s likely to be difficult because this measure is dependent on your patients taking action rather than you quantifying something. In other words, it’s out of your control. Or is it? How might you engage your patients after they’ve left your office?

Answer: Give them a good reason to want to communicate with you electronically. Create opportunities for them to message you and avoid lengthy hold times on the phone. Enable your patients to set appointments or request prescription refills electronically which gives them the freedom to address their own needs, regardless of your business hours. This can all be accomplished with your patient portal.

Remember the long term purpose of Meaningful Use is to provide better patient care by standardizing medical records for better sharing, and to engage the patient in their care. This is an excellent step toward that.

Check back here frequently for help with more of the MU2 core measures. And if you have any questions, contact us at MeaningfulUse@eyefinity.com or visit us online at eyefinity.com/mu2.